Skip to content

Screener

Eligibility screening

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant

Sponsored by Novartis PharmaceuticalsStudy detailsClinicalTrials.gov

6 US sites in CA, KS, PA, TX +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.